Literature DB >> 8358193

Elevation of carcinoembryonic antigen related to biliary malignancy in hepatolithiasis.

C G Ker1, P C Sheen, C H Chien, C C Wu.   

Abstract

Bile duct neoplasms occur relatively often in patients with hepatolithiasis in Taiwan. In this study, 49 patients with a positive immunoperoxidase stain for carcinoembryonic antigen (CEA) in the bile duct glands were examined in relation to the concentration of CEA in serum and bile. The bile concentrations of CEA in 15 control patients, 16 patients with hepatolithiasis only, 7 with hepatolithiasis and bile duct carcinoma, and 11 with bile duct carcinoma only were 4.09 +/- 4.12, 70.49 +/- 81.62, 137.73 +/- 66.15, and 144.3 +/- 117.31 ng/ml (mean +/- SD), respectively. A positive CEA stain from the bile duct was seen in 13.33%, 81.23%, 85.71%, and 90.91% of each group, respectively. No strongly positive staining, (2+ or 3+) was found in the control group, but it was found frequently in the hepatolithiasis and bile duct carcinoma groups. The findings of this study therefore suggest the probability of a combined neoplasm in patients with hepatolithiasis if the CEA value is unusually elevated in the serum or bile.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358193     DOI: 10.1007/bf00730623

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  [Carcinoembryonic antigen (author's transl)].

Authors:  N Yamaguchi; H Inoue; H Ogawa; H Ohomi; K Kimoto; M Machino; H Ikeuchi; S Takeuchi; K Hayashi; A Aoike; Y Akasaka; K Kawai
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1979-06

2.  [The value of bile carcinoembryonic antigen in the differentiation of benign from malignant biliary obstruction].

Authors:  Y C Kuo; K M Fang; C S Wu; Y F Liaw
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1985-05

3.  Carcinoembryonic antigen and the liver.

Authors:  M S Loewenstein; N Zamcheck
Journal:  Gastroenterology       Date:  1977-01       Impact factor: 22.682

4.  A study of CEA, CA 19-9 and CA 125 in biliary tract diseases.

Authors:  C G Ker; C C Wu; J S Chen; M F Hou; K T Lee; P C Sheen
Journal:  Gaoxiong Yi Xue Ke Xue Za Zhi       Date:  1989-02

5.  Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias.

Authors:  B Bätge; K Bosslet; H H Sedlacek; H F Kern; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

6.  Carcinoembryonic antigen in the bile in patients with pancreatic and biliary cancer. Correlation with cytology and percutaneous transhepatic cholangiography.

Authors:  M Tatsuta; H Yamamura; R Yamamoto; T Morii; S Okuda; H Tamura
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860

7.  Carcinoembryonic antigen in serum in diseases of the liver and pancreas.

Authors:  S K Khoo; I R Mackay
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

8.  Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD.

Authors:  F Buchegger; M Schreyer; S Carrel; J P Mach
Journal:  Int J Cancer       Date:  1984-05-15       Impact factor: 7.396

9.  Cholangiocarcinoma in hepatolithiasis.

Authors:  P H Chen; H W Lo; C S Wang; K R Tsai; Y C Chen; K Y Lin; C P Siauw; R R Hwang; M H Liu; H C Ko
Journal:  J Clin Gastroenterol       Date:  1984-12       Impact factor: 3.062

10.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.